Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testis | 4 | 2020 | 40 | 1.990 |
Why?
|
| Zinc | 4 | 2020 | 63 | 1.950 |
Why?
|
| Exosomes | 6 | 2024 | 96 | 1.350 |
Why?
|
| Superoxide Dismutase-1 | 3 | 2018 | 51 | 1.100 |
Why?
|
| Mitochondria | 5 | 2024 | 418 | 1.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2021 | 68 | 0.960 |
Why?
|
| Smoke | 3 | 2021 | 37 | 0.920 |
Why?
|
| Epididymis | 3 | 2020 | 8 | 0.880 |
Why?
|
| Mitochondrial Proteins | 2 | 2021 | 80 | 0.810 |
Why?
|
| Animal Feed | 1 | 2020 | 21 | 0.640 |
Why?
|
| Glutathione Peroxidase | 2 | 2016 | 26 | 0.600 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2020 | 98 | 0.590 |
Why?
|
| Diet | 1 | 2020 | 241 | 0.550 |
Why?
|
| Protective Agents | 2 | 2018 | 17 | 0.550 |
Why?
|
| Cyclophosphamide | 2 | 2018 | 43 | 0.540 |
Why?
|
| NM23 Nucleoside Diphosphate Kinases | 1 | 2016 | 2 | 0.510 |
Why?
|
| Germ Cells | 1 | 2016 | 15 | 0.510 |
Why?
|
| Methotrexate | 1 | 2016 | 36 | 0.500 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2020 | 554 | 0.490 |
Why?
|
| Tobacco Smoking | 3 | 2021 | 38 | 0.480 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 346 | 0.480 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2016 | 124 | 0.440 |
Why?
|
| Rats | 5 | 2024 | 1594 | 0.440 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2014 | 22 | 0.420 |
Why?
|
| Copper | 2 | 2024 | 49 | 0.400 |
Why?
|
| Lung | 3 | 2021 | 385 | 0.390 |
Why?
|
| Animals | 10 | 2025 | 10767 | 0.380 |
Why?
|
| Water Pipe Smoking | 2 | 2020 | 8 | 0.330 |
Why?
|
| Oxidative Stress | 4 | 2020 | 684 | 0.310 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 645 | 0.280 |
Why?
|
| Ditiocarb | 2 | 2018 | 6 | 0.260 |
Why?
|
| MicroRNAs | 2 | 2021 | 303 | 0.260 |
Why?
|
| Testosterone | 2 | 2020 | 74 | 0.250 |
Why?
|
| DNA Damage | 3 | 2018 | 153 | 0.240 |
Why?
|
| Male | 8 | 2024 | 14057 | 0.230 |
Why?
|
| Menkes Kinky Hair Syndrome | 1 | 2024 | 1 | 0.220 |
Why?
|
| Mice | 4 | 2024 | 4848 | 0.220 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2024 | 3 | 0.210 |
Why?
|
| Fibroblasts | 2 | 2024 | 160 | 0.210 |
Why?
|
| Atherosclerosis | 1 | 2025 | 97 | 0.210 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2024 | 79 | 0.200 |
Why?
|
| Kidney Neoplasms | 1 | 2024 | 103 | 0.190 |
Why?
|
| Extracellular Vesicles | 1 | 2024 | 54 | 0.190 |
Why?
|
| Macrophages | 1 | 2025 | 307 | 0.180 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 8 | 0.180 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 477 | 0.170 |
Why?
|
| GTP Phosphohydrolases | 1 | 2021 | 19 | 0.170 |
Why?
|
| Biomarkers | 2 | 2024 | 787 | 0.170 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 32 | 0.160 |
Why?
|
| Blood Urea Nitrogen | 1 | 2020 | 13 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 360 | 0.160 |
Why?
|
| Alarmins | 1 | 2019 | 3 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 29 | 0.150 |
Why?
|
| Triglycerides | 1 | 2020 | 123 | 0.150 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2019 | 25 | 0.150 |
Why?
|
| Transcriptome | 1 | 2021 | 244 | 0.150 |
Why?
|
| Smokers | 1 | 2020 | 129 | 0.150 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 1522 | 0.150 |
Why?
|
| Cholesterol | 1 | 2020 | 204 | 0.140 |
Why?
|
| Insulin | 1 | 2020 | 325 | 0.140 |
Why?
|
| Cigarette Smoking | 1 | 2019 | 85 | 0.140 |
Why?
|
| Vaping | 1 | 2020 | 143 | 0.140 |
Why?
|
| Tobacco Products | 1 | 2021 | 209 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2019 | 267 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2018 | 61 | 0.130 |
Why?
|
| Cytokines | 1 | 2019 | 457 | 0.130 |
Why?
|
| Catalase | 1 | 2016 | 50 | 0.120 |
Why?
|
| Spermatozoa | 1 | 2016 | 34 | 0.120 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2020 | 222 | 0.120 |
Why?
|
| Humans | 8 | 2025 | 29096 | 0.110 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2014 | 3 | 0.100 |
Why?
|
| Metallothionein | 1 | 2014 | 3 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2020 | 740 | 0.100 |
Why?
|
| Sperm Motility | 1 | 2014 | 16 | 0.100 |
Why?
|
| Organ Size | 1 | 2014 | 88 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2016 | 274 | 0.100 |
Why?
|
| Body Weight | 1 | 2014 | 253 | 0.100 |
Why?
|
| Biological Transport | 2 | 2024 | 128 | 0.100 |
Why?
|
| ROC Curve | 2 | 2024 | 144 | 0.090 |
Why?
|
| Phenotype | 2 | 2024 | 688 | 0.090 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 82 | 0.080 |
Why?
|
| Hydrazines | 1 | 2024 | 13 | 0.050 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2025 | 49 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2024 | 64 | 0.050 |
Why?
|
| Nephrectomy | 1 | 2024 | 48 | 0.050 |
Why?
|
| Aged | 2 | 2024 | 5627 | 0.050 |
Why?
|
| Cell Line | 1 | 2024 | 701 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 485 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2022 | 50 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2024 | 171 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 26 | 0.040 |
Why?
|
| Homeostasis | 1 | 2022 | 122 | 0.040 |
Why?
|
| Prognosis | 1 | 2024 | 815 | 0.040 |
Why?
|
| Female | 3 | 2024 | 15748 | 0.040 |
Why?
|
| Middle Aged | 2 | 2024 | 7458 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 415 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2024 | 828 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2024 | 1286 | 0.040 |
Why?
|
| Adult | 2 | 2024 | 8081 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2020 | 194 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 1362 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2019 | 203 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2019 | 216 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2018 | 119 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 1023 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 2070 | 0.030 |
Why?
|
| Kidney | 1 | 2018 | 289 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 1485 | 0.020 |
Why?
|